Products

Periodontal Testing with MyPerioPath® & MyPerioID® PST®

Education

Learn how to administer the tests and more.

> GET STARTED


Purchase our salivary diagnostic tests.

Periodontal Testing

with MyPerioPath® & MyPerioID® PST®

Oral HPV Testing

with the OraRisk® HPV test

Get Started

Buy OralDNA® Labs Products Now

Mailing List

Interested in receiving product news and updates?



MyPerioID® PST®

The MyPerioID® PST® test identifies individual genetic susceptibility to periodontal disease and enables the clinician to establish which patients are at increased risk for more severe periodontal infections due to an exaggerated immune response.

Who should be tested?

  • Patients with a family history of periodontal disease
  • Patients with compromised immune systems
  • Patients that have received therapy but continue with disease activity
  • Patients that will receive implants and have lost teeth to periodontal disease
  • Adolescent patients

Click to view sample MyPerioID® PST® report

The MyPerioID® PST® test is quickly and easily administered chairside, and takes about a minute to complete. Here’s the process:

  1. Patient swishes a sterile saline solution for 30 seconds
  2. Patient expectorates into funneled collection tube
  3. Funnel is removed, cap is secured to top of collection tube
  4. Samples are sent via pre-paid FedEx® envelope to OralDNA® Labs for DNA-PCR analysis
  5. E-mail notification is sent to clinician when electronic result report is available

MyPerioPath®

The MyPerioPath® salivary diagnostic test identifies the type and concentration of specific perio-pathogenic bacteria that are known to cause periodontal disease. MyPerioPath® helps support the clinician with better risk assessment and personalized treatment options for more predictable outcomes.

Who should be tested?

  • Patients presenting with signs and symptoms of a periodontal infection
  • Patients with pockets of 4mm or greater with clinical signs of a periodontal infection
  • Patients presenting chronic periodontal disease who are not responding positively to their current treatment
  • Patients with Type 1 or Type 2 diabetes
  • Patients with a history of cardiovascular disease
  • Patients who use tobacco products
  • Patients who will undergo surgical procedures or radiation treatment
  • Can be used for establishing a “baseline” for any patient who may be at increased risk for periodontal infections
  • Patients who test positive for genetic susceptibility with the MyPerioID® PST® test
  • Women of childbearing age

Click to view sample
MyPerioPath® report

The MyPerioPath® test is quickly and easily administered chairside, and takes about a minute to complete. Here’s
the process:

  1. Patient swishes a sterile saline solution for 30 seconds
  2. Patient expectorates into funneled collection tube
  3. Funnel is removed, cap is secured to top of collection tube
  4. Samples are sent via pre-paid FedEx® envelope to OralDNA® Labs for DNA-PCR analysis
  5. E-mail notification is sent to clinician when electronic result report is available